News
-
-
-
COMMUNIQUÉ DE PRESSE
Bluejay Diagnostics Announces SYMON-II Clinical Dataset Details Supporting Evaluation of Mortality Risk in Sepsis and Septic Shock
Bluejay Diagnostics, Inc. announces baseline clinical characteristics from SYMON-II study, evaluating IL-6 as a biomarker for patients with sepsis and septic shock